Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McMaster University

$17,500.00

Pre-Existing Immunity Prior to Heparin Exposure Enhances Susceptibility Towards Heparin-induced Thrombocytopenia

EF 2014-15

Résumé
Background: Heparin-induced thrombocytopenia (HIT) is an adverse immunological response towards the anticoagulant, heparin. In HIT, heparin (H) interacts with the peptide, platelet-factor 4 (PF4), to produce PF4/H complexes, which are bound by anti-PF4/H antibodies. These antibodies induce platelet activation, leading to a diminished platelet count and sometimes life-threatening thrombosis. Furthermore, anti-PF4/H antibody production and HIT-onset is more common in cardiac surgery patients than the general population. In addition, research has suggested that the immune cells of some healthy individuals are sensitized to PF4/H prior to heparin therapy. Thus, we hypothesize that the immune response prior to heparin therapy can be utilized to identify cardiac surgery patients who are more likely to produce anti-PF4/H antibodies and develop HIT postoperatively. Objectives: We will determine both in vitro PF4/H-induced immune cell proliferation and anti-PF4/H antibody production within patients before and after cardiac surgery. Methods: White blood cells (WBCs) will be isolated from the peripheral blood of patients before and 5–7 days after cardiac surgery. Utilizing these WBCs, we will determine the level of cellular division by measuring the incorporation of radioactively-labeled genetic material. Also, we will determine anti-PF4/H antibody production by measuring the quantity of PF4/H-specific antibodies within the secretions of stimulated WBCs isolated from the same surgery patients pre- and postoperatively. Significance: Through this research, we hope to identify those patients who are at-risk of developing HIT prior to heparin therapy, and thus prevent the administration of heparin and subsequent onset of HIT.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
331466
Name
Staibano Phillip
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Pre-Existing Immunity Prior to Heparin Exposure Enhances Susceptibility Towards Heparin-induced Thrombocytopenia
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antibodies; Coronary Artery Bypass Grafting; Heparin; Immune Sensitization; Immunology; Platelet-Factor 4; Platelets; Thrombocytopenia; Thrombosis; Translational Medicine
Abstract
Background: Heparin-induced thrombocytopenia (HIT) is an adverse immunological response towards the anticoagulant, heparin. In HIT, heparin (H) interacts with the peptide, platelet-factor 4 (PF4), to produce PF4/H complexes, which are bound by anti-PF4/H antibodies. These antibodies induce platelet activation, leading to a diminished platelet count and sometimes life-threatening thrombosis. Furthermore, anti-PF4/H antibody production and HIT-onset is more common in cardiac surgery patients than the general population. In addition, research has suggested that the immune cells of some healthy individuals are sensitized to PF4/H prior to heparin therapy. Thus, we hypothesize that the immune response prior to heparin therapy can be utilized to identify cardiac surgery patients who are more likely to produce anti-PF4/H antibodies and develop HIT postoperatively. Objectives: We will determine both in vitro PF4/H-induced immune cell proliferation and anti-PF4/H antibody production within patients before and after cardiac surgery. Methods: White blood cells (WBCs) will be isolated from the peripheral blood of patients before and 5–7 days after cardiac surgery. Utilizing these WBCs, we will determine the level of cellular division by measuring the incorporation of radioactively-labeled genetic material. Also, we will determine anti-PF4/H antibody production by measuring the quantity of PF4/H-specific antibodies within the secretions of stimulated WBCs isolated from the same surgery patients pre- and postoperatively. Significance: Through this research, we hope to identify those patients who are at-risk of developing HIT prior to heparin therapy, and thus prevent the administration of heparin and subsequent onset of HIT.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Staibano, Phillip
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~